glp 1 and bipolar semaglutide disorder The GLP-1 receptor agonist liraglutide reverses mania-like alterations and memory New research links genetic activation
Description
Moon, S
Dosing and Administration Strategy Stability is Key: Patients on a stable dose generally do not need adjustments
In 2021, it was approved for chronic weight management as Wegovy
analysis and interpretation of data: CWC
Liraglutide 3.0 mg (Saxenda
